$ACCD
Accolade, Inc.

2022 Q3 Form 10-Q Financial Statement

#000155837022014888 Filed on October 06, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2021 Q3
Revenue $87.64M $73.29M
YoY Change 19.59% 99.22%
Cost Of Revenue $49.83M $44.33M
YoY Change 12.4% 110.41%
Gross Profit $37.81M $28.95M
YoY Change 30.6% 84.19%
Gross Profit Margin 43.14% 39.51%
Selling, General & Admin $45.96M $50.18M
YoY Change -8.42% 250.07%
% of Gross Profit 121.53% 173.31%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $11.57M $11.02M
YoY Change 4.99% 437.61%
% of Gross Profit 30.6% 38.06%
Operating Expenses $83.72M $103.4M
YoY Change -19.03% 261.29%
Operating Profit -$45.91M -$74.44M
YoY Change -38.33% 477.0%
Interest Expense -$236.0K -$776.0K
YoY Change -69.59% -66.94%
% of Operating Profit
Other Income/Expense, Net -$130.0K $11.00K
YoY Change -1281.82% -110.58%
Pretax Income -$46.27M -$75.21M
YoY Change -38.47% 389.87%
Income Tax $249.0K -$12.85M
% Of Pretax Income
Net Earnings -$46.52M -$62.36M
YoY Change -25.4% 305.73%
Net Earnings / Revenue -53.08% -85.09%
Basic Earnings Per Share -$0.66 -$0.97
Diluted Earnings Per Share -$0.66 -$968.3K
COMMON SHARES
Basic Shares Outstanding 70.48M 66.66M
Diluted Shares Outstanding 70.48M 64.40M

Balance Sheet

Concept 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $330.6M $384.0M
YoY Change -13.9% 72.9%
Cash & Equivalents $330.6M $384.0M
Short-Term Investments
Other Short-Term Assets $13.55M $14.89M
YoY Change -9.01% 50.37%
Inventory
Prepaid Expenses
Receivables $23.49M $15.85M
Other Receivables $0.00 $0.00
Total Short-Term Assets $374.8M $417.6M
YoY Change -10.25% 71.97%
LONG-TERM ASSETS
Property, Plant & Equipment $12.31M $12.18M
YoY Change 1.03% 3.86%
Goodwill $278.2M $575.7M
YoY Change -51.67% 14244.88%
Intangibles $223.9M $255.2M
YoY Change -12.24% 19099.85%
Long-Term Investments
YoY Change
Other Assets $1.362M $1.921M
YoY Change -29.1% 40.94%
Total Long-Term Assets $556.9M $852.2M
YoY Change -34.65% 3444.86%
TOTAL ASSETS
Total Short-Term Assets $374.8M $417.6M
Total Long-Term Assets $556.9M $852.2M
Total Assets $931.7M $1.270B
YoY Change -26.63% 375.8%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.09M $8.696M
YoY Change 27.58% 128.18%
Accrued Expenses $48.04M $6.777M
YoY Change 608.93% 157.58%
Deferred Revenue $45.01M $43.12M
YoY Change 4.38% 31.56%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $112.7M $249.4M
YoY Change -54.83% 261.79%
LONG-TERM LIABILITIES
Long-Term Debt $281.5M $279.8M
YoY Change 0.59%
Other Long-Term Liabilities $203.0K $6.990M
YoY Change -97.1% 20.52%
Total Long-Term Liabilities $203.0K $286.8M
YoY Change -99.93% 4845.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $112.7M $249.4M
Total Long-Term Liabilities $203.0K $286.8M
Total Liabilities $425.4M $536.2M
YoY Change -20.67% 617.15%
SHAREHOLDERS EQUITY
Retained Earnings -$884.0M -$482.6M
YoY Change 83.18% 37.8%
Common Stock $7.000K $7.000K
YoY Change 0.0% 40.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $506.3M $733.6M
YoY Change
Total Liabilities & Shareholders Equity $931.7M $1.270B
YoY Change -26.63% 375.8%

Cashflow Statement

Concept 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$46.52M -$62.36M
YoY Change -25.4% 305.73%
Depreciation, Depletion And Amortization $11.57M $11.02M
YoY Change 4.99% 437.61%
Cash From Operating Activities -$2.993M -$11.03M
YoY Change -72.86% -26.66%
INVESTING ACTIVITIES
Capital Expenditures -$1.632M -$1.228M
YoY Change 32.9% 49.76%
Acquisitions
YoY Change
Other Investing Activities $0.00 $66.14M
YoY Change -100.0% -110330.0%
Cash From Investing Activities -$1.632M $64.91M
YoY Change -102.51% -7560.92%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -370.0K 4.615M
YoY Change -108.02% -97.12%
NET CHANGE
Cash From Operating Activities -2.993M -11.03M
Cash From Investing Activities -1.632M 64.91M
Cash From Financing Activities -370.0K 4.615M
Net Change In Cash -4.995M 58.49M
YoY Change -108.54% -59.5%
FREE CASH FLOW
Cash From Operating Activities -$2.993M -$11.03M
Capital Expenditures -$1.632M -$1.228M
Free Cash Flow -$1.361M -$9.802M
YoY Change -86.12% -31.07%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
accd Product And Technology Expense
ProductAndTechnologyExpense
38451000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70251890
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
80270000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61332729
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-5782000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-474000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-75000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
322000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3792000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-33454000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-38644000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
99998000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
99998000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
1499000
us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
356000
us-gaap Net Income Loss
NetIncomeLoss
-389345000
us-gaap Net Income Loss
NetIncomeLoss
-111071000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1405000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1573000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
261873000
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.66
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
23489000
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.97
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-08-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39348
dei Entity Registrant Name
EntityRegistrantName
ACCOLADE, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
01-0969591
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
dei Entity Address Address Line1
EntityAddressAddressLine1
1201 Third Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1700
dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98101
dei City Area Code
CityAreaCode
206
dei Local Phone Number
LocalPhoneNumber
926-8100
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
ACCD
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71938910
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
330633000
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
365853000
CY2022Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.66
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.81
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70475778
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64404223
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70251890
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61332729
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P6M
CY2022Q3 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P1Y
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70475778
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
64404223
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70251890
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
61332729
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.66
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.54
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.81
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
67098477
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71538377
dei Entity Central Index Key
EntityCentralIndexKey
0001481646
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--02-28
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
dei Amendment Flag
AmendmentFlag
false
accd Goodwill Impairment Adjustment Per Shares Diluted
GoodwillImpairmentAdjustmentPerSharesDiluted
4.27
dei Document Type
DocumentType
10-Q
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
21116000
CY2022Q3 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
7119000
CY2022Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
9685000
CY2022Q3 accd Deferred Acquisition Costs Current
DeferredAcquisitionCostsCurrent
3445000
CY2022Q1 accd Deferred Acquisition Costs Current
DeferredAcquisitionCostsCurrent
3015000
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
10101000
CY2022Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
9468000
CY2022Q3 us-gaap Assets Current
AssetsCurrent
374787000
CY2022Q1 us-gaap Assets Current
AssetsCurrent
409137000
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
12306000
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11797000
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32300000
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
33126000
CY2022Q3 us-gaap Goodwill
Goodwill
278191000
CY2022Q1 us-gaap Goodwill
Goodwill
577896000
CY2022Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
223946000
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
244690000
CY2022Q3 accd Deferred Acquisition Costs Non Current
DeferredAcquisitionCostsNonCurrent
8792000
CY2022Q1 accd Deferred Acquisition Costs Non Current
DeferredAcquisitionCostsNonCurrent
7205000
CY2022Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1362000
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1678000
CY2022Q3 us-gaap Assets
Assets
931684000
CY2022Q1 us-gaap Assets
Assets
1285529000
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
11094000
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
7837000
CY2022Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
9931000
CY2022Q1 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
11000000
CY2022Q3 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
30940000
CY2022Q1 us-gaap Workers Compensation Liability Current
WorkersCompensationLiabilityCurrent
39189000
CY2022Q3 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
8519000
CY2022Q1 us-gaap Contract With Customer Refund Liability Current
ContractWithCustomerRefundLiabilityCurrent
16263000
CY2022Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
45005000
CY2022Q1 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
30875000
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
7173000
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6589000
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
112662000
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
111753000
CY2022Q3 us-gaap Long Term Loans Payable
LongTermLoansPayable
281500000
CY2022Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
280666000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
30721000
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
32486000
CY2022Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
203000
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4562000
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
284000
CY2022Q1 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
268000
CY2022Q3 us-gaap Liabilities
Liabilities
425370000
CY2022Q1 us-gaap Liabilities
Liabilities
429735000
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71538377
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
67098477
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
7000
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
7000
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1390296000
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1350431000
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-883989000
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-494644000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
506314000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
855794000
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
931684000
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1285529000
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
87643000
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73288000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
173171000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
132815000
CY2022Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
49830000
CY2021Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
44334000
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
97445000
CY2022Q3 accd Product And Technology Expense
ProductAndTechnologyExpense
26194000
CY2021Q3 accd Product And Technology Expense
ProductAndTechnologyExpense
22512000
accd Product And Technology Expense
ProductAndTechnologyExpense
53011000
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
24936000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
24009000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
50550000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
38518000
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21020000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
26170000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
41258000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
48172000
CY2022Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11571000
CY2021Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
11021000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
23147000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
19717000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
299705000
CY2021Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
19686000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
30146000
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
83721000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
103398000
us-gaap Operating Expenses
OperatingExpenses
467671000
us-gaap Operating Expenses
OperatingExpenses
175004000
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-45908000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-74444000
us-gaap Operating Income Loss
OperatingIncomeLoss
-391945000
us-gaap Operating Income Loss
OperatingIncomeLoss
-122459000
CY2022Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-236000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-776000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-870000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-1394000
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-130000
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
11000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-180000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-44000
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-46274000
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-75209000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-392995000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-123897000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
249000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12845000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3650000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12826000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-46523000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-62364000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.81
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70475778
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64404223
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
390848000
CY2021Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
116187000
CY2021Q2 accd Issuance Of Replacement Awards In Connection With Acquisition
IssuanceOfReplacementAwardsInConnectionWithAcquisition
1520000
CY2021Q2 accd Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueStockOptionsExercisedAndVestingOfRestrictedStockUnits
2141000
CY2021Q2 accd Adjustments To Additional Paid In Capital Capped Calls Purchased
AdjustmentsToAdditionalPaidInCapitalCappedCallsPurchased
34503000
CY2021Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1948000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7675000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-48707000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
437109000
CY2021Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
330338000
CY2021Q3 accd Issuance Of Replacement Awards In Connection With Acquisition
IssuanceOfReplacementAwardsInConnectionWithAcquisition
5209000
CY2021Q3 accd Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueStockOptionsExercisedAndVestingOfRestrictedStockUnits
3491000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19775000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-62364000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
733558000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
855794000
CY2022Q2 accd Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueStockOptionsExercisedAndVestingOfRestrictedStockUnits
358000
CY2022Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1788000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19389000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-342822000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
534507000
CY2022Q3 accd Stock Issued During Period Value Stock Options Exercised And Vesting Of Restricted Stock Units
StockIssuedDuringPeriodValueStockOptionsExercisedAndVestingOfRestrictedStockUnits
816000
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17514000
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-46523000
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
506314000
us-gaap Profit Loss
ProfitLoss
-389345000
us-gaap Profit Loss
ProfitLoss
-111071000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
299705000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23147000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
19717000
accd Amortization Of Deferred Contract Acquisition Costs
AmortizationOfDeferredContractAcquisitionCosts
1713000
accd Amortization Of Deferred Contract Acquisition Costs
AmortizationOfDeferredContractAcquisitionCosts
1246000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
30146000
accd Deferred Income Tax Expense Benefit Related To Acquisition
DeferredIncomeTaxExpenseBenefitRelatedToAcquisition
3859000
accd Deferred Income Tax Expense Benefit Related To Acquisition
DeferredIncomeTaxExpenseBenefitRelatedToAcquisition
12865000
us-gaap Paid In Kind Interest
PaidInKindInterest
838000
us-gaap Paid In Kind Interest
PaidInKindInterest
823000
us-gaap Share Based Compensation
ShareBasedCompensation
36903000
us-gaap Share Based Compensation
ShareBasedCompensation
27450000
accd Increase Decrease In Accounts Receivable And Unbilled Revenue
IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue
-193000
accd Increase Decrease In Accounts Receivable And Unbilled Revenue
IncreaseDecreaseInAccountsReceivableAndUnbilledRevenue
-1440000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3623000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-267000
accd Increase Decrease In Deferred Contract Acquisition Costs
IncreaseDecreaseInDeferredContractAcquisitionCosts
3730000
accd Increase Decrease In Deferred Contract Acquisition Costs
IncreaseDecreaseInDeferredContractAcquisitionCosts
2349000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
6403000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
16735000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-8249000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-2904000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-263802000
accd Proceeds From Stock Option And Warrant Exercises
ProceedsFromStockOptionAndWarrantExercises
1178000
accd Proceeds From Stock Option And Warrant Exercises
ProceedsFromStockOptionAndWarrantExercises
5654000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
60000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8368000
accd Payment For Purchase Of Capped Calls
PaymentForPurchaseOfCappedCalls
34443000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
1788000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
2282000
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
287500000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
1828000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1138000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
252565000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-35220000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-49881000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
365853000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
433884000
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
330633000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
384003000
us-gaap Interest Paid Net
InterestPaidNet
820000
us-gaap Interest Paid Net
InterestPaidNet
102000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
429000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
166000
accd Other Receivable Related To Stock Option Exercises
OtherReceivableRelatedToStockOptionExercises
4000
accd Other Receivable Related To Stock Option Exercises
OtherReceivableRelatedToStockOptionExercises
75000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
22000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
60000
us-gaap Stock Issued1
StockIssued1
446525000
accd Replacement Awards Issued In Connection With Acquisition
ReplacementAwardsIssuedInConnectionWithAcquisition
6729000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
7670000
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
2623000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
94756000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
94071000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
49164000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 18pt;"><span style="font-style:italic;"> (</span><span style="font-style:italic;">h</span><span style="font-style:italic;">)  Concentration of Credit Risk</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Financial instruments that potentially subject the Company to credit risk consist principally of cash, cash equivalents, and marketable securities. The Company maintains its cash primarily with domestic financial institutions of high credit quality, which may exceed federal deposit insurance corporation limits. The Company invests its cash equivalents in highly rated money market funds. Marketable securities are comprised of United States treasury bills with original maturities greater than 90 days. The Company has not experienced any losses in such accounts. The Company believes it is not exposed to any significant credit risk on cash, cash equivalents, and marketable securities and performs periodic evaluations of the credit standing of such institutions.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">Significant customers are those which represent 10% or more of the Company’s revenue during the periods. For each significant customer, revenue as a percentage of total revenue was as follows:</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;min-height:0.0pt;margin:0pt;"><span style="font-size:0pt;visibility:hidden;">​</span></p><table style="border-collapse:collapse;font-size:16pt;height:max-content;margin-left:auto;margin-right:auto;padding-left:0pt;padding-right:0pt;width:75.22%;"><tr style="height:1pt;"><td style="vertical-align:bottom;width:21.16%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.72%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:3.68%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:16.73%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.32%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:4.12%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:15.29%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><div style="height:1pt;overflow:hidden;overflow-wrap:break-word;position:relative;"><div style="bottom:0pt;position:absolute;width:100%;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:1pt;visibility:hidden;">​</span></p></div></div></td></tr><tr><td style="vertical-align:bottom;width:21.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:center;margin:0pt;"><span style="border-bottom-style:solid;border-bottom-width:0.5pt;font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:double;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:37.14%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the three months ended August 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="border-bottom-style:solid;border-bottom-width:0.5pt;font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:double;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="border-bottom-style:solid;border-bottom-width:0.5pt;font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:double;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="border-bottom-style:solid;border-bottom-width:0.5pt;font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:double;visibility:hidden;">​</span></p></td><td colspan="3" style="vertical-align:bottom;white-space:nowrap;width:34.74%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">For the six months ended August 31, </b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="border-bottom-style:solid;border-bottom-width:0.5pt;font-size:8pt;font-weight:bold;text-decoration-line:underline;text-decoration-style:double;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:21.16%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.72%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.68%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.73%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.32%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2022</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.12%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;margin:0pt;">    </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.29%;border-bottom:1px solid #000000;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:8pt;text-align:center;margin:0pt;"><b style="font-weight:bold;">2021</b></p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="font-size:8pt;font-weight:bold;visibility:hidden;">​</span></p></td></tr><tr><td style="vertical-align:bottom;width:21.16%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">Customer 1</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.2%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"> </p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.72%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:3.68%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:16.73%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 9.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:0.08%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.32%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;">*</p></td><td style="vertical-align:bottom;white-space:nowrap;width:4.12%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%  </p></td><td style="vertical-align:bottom;white-space:nowrap;width:15.29%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:right;margin:0pt 3pt 0pt 0pt;"> 10.7</p></td><td style="vertical-align:bottom;white-space:nowrap;width:2.28%;background:#cceeff;margin:0pt;padding:0pt;"><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;">%</p></td></tr></table><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt;"><span style="visibility:hidden;">​</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">*For the three and six months ended August 31, 2022, no customer represented 10% or more of the Company’s revenue.</p>
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
34739000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
38740000
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
87643000
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
73288000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
173171000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
132815000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
245661000
CY2022Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
245661000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
29550000
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
23746000
CY2022Q3 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
794000
CY2021Q3 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
1348000
us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
2758000
CY2022Q3 us-gaap Capitalized Contract Cost Amortization Period
CapitalizedContractCostAmortizationPeriod
P5Y
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2021Q3 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2022Q3 us-gaap Capitalized Contract Cost Impairment Loss
CapitalizedContractCostImpairmentLoss
0
CY2021Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
74629000
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
147161000
CY2021Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-62491000
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-125590000
CY2021Q3 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
4517000
us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
12897000
CY2022Q1 us-gaap Goodwill
Goodwill
577896000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
299705000
CY2022Q3 us-gaap Goodwill
Goodwill
278191000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
299705000
accd Goodwill Impairment Adjustment Per Shares Basic
GoodwillImpairmentAdjustmentPerSharesBasic
4.27
CY2022Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
CY2022Q3 accd Goodwill Impairment Test Discount Rate
GoodwillImpairmentTestDiscountRate
0.11
CY2022Q3 accd Goodwill Impairment Test For Current Revenue
GoodwillImpairmentTestForCurrentRevenue
1.1
CY2022Q3 accd Goodwill Impairment Test For Forward Revenue
GoodwillImpairmentTestForForwardRevenue
1.8
accd Excess Of Fair Value Over Carrying Value
ExcessOfFairValueOverCarryingValue
0
CY2022Q3 us-gaap Line Of Credit
LineOfCredit
1425000
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
283576000
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
59630000
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
223946000
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10372000
CY2021Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9533000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
20744000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
16138000
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1889000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
1809000
us-gaap Operating Lease Cost
OperatingLeaseCost
3838000
us-gaap Operating Lease Cost
OperatingLeaseCost
3569000
CY2022Q3 us-gaap Variable Lease Cost
VariableLeaseCost
537000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
437000
us-gaap Variable Lease Cost
VariableLeaseCost
967000
us-gaap Variable Lease Cost
VariableLeaseCost
781000
CY2022Q3 us-gaap Lease Cost
LeaseCost
2426000
CY2021Q3 us-gaap Lease Cost
LeaseCost
2246000
us-gaap Lease Cost
LeaseCost
4805000
us-gaap Lease Cost
LeaseCost
4350000
us-gaap Operating Lease Payments
OperatingLeasePayments
4166000
us-gaap Operating Lease Payments
OperatingLeasePayments
4133000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2155000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
3356000
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y8M12D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.049
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
4462000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
8857000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
7278000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7245000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6429000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
9408000
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
43679000
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
5785000
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
37894000
CY2022Q3 us-gaap Notes Payable Fair Value Disclosure
NotesPayableFairValueDisclosure
206943000
CY2022Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
17514000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19775000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36903000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27450000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Accelerated Compensation Cost
ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost
3139000
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
249000
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12845000
CY2022Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.005
CY2021Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.171
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3650000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-12826000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.009
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.104
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-46523000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-62364000
us-gaap Net Income Loss
NetIncomeLoss
-389345000
us-gaap Net Income Loss
NetIncomeLoss
-111071000
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70475778
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64404223
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
70251890
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
61332729
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.66
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.97
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.54
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.81
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20554983
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
20977607
CY2022Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
888000
CY2022Q3 us-gaap Purchase Obligation
PurchaseObligation
40323000
CY2022Q3 accd Purchase Obligation Remaining Future Purchase Commitments
PurchaseObligationRemainingFuturePurchaseCommitments
35440000

Files In Submission

Name View Source Status
0001558370-22-014888-index-headers.html Edgar Link pending
0001558370-22-014888-index.html Edgar Link pending
0001558370-22-014888.txt Edgar Link pending
0001558370-22-014888-xbrl.zip Edgar Link pending
accd-20220831.xsd Edgar Link pending
accd-20220831x10q.htm Edgar Link pending
accd-20220831xex10d1.htm Edgar Link pending
accd-20220831xex31d1.htm Edgar Link pending
accd-20220831xex31d2.htm Edgar Link pending
accd-20220831xex32d1.htm Edgar Link pending
accd-20220831x10q_htm.xml Edgar Link completed
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
accd-20220831_def.xml Edgar Link unprocessable
accd-20220831_lab.xml Edgar Link unprocessable
accd-20220831_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
accd-20220831_cal.xml Edgar Link unprocessable